{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:15:55Z","timestamp":1791569755659,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.autrev.2016.12.002","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T01:51:26Z","timestamp":1481766686000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A\/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sj\u00f6gren's syndrome: An updated meta-analysis"],"prefix":"10.1016","volume":"16","author":[{"given":"Sen Hee","family":"Tay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Marie","family":"Fairhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.12.002_bb0005","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/art.39111","article-title":"Mood disorders in systemic lupus erythematosus: results from an international inception cohort study","volume":"67","author":"Hanly","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0010","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2008.098301","article-title":"Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study","volume":"68","author":"Harboe","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.12.002_bb0015","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1177\/0961203308097568","article-title":"The neuropsychiatric SLE SLICC inception cohort study","volume":"17","author":"Hanly","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.12.002_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1191\/0961203304lu2024oa","article-title":"ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables","volume":"13","author":"Hanly","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.12.002_bb0030","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/art.38852","article-title":"Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-d-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjogren's syndrome","volume":"66","author":"Lauvsnes","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.12.002_bb0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard.2010.138792","article-title":"SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.12.002_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncpneuro0033","article-title":"Autoimmune channelopathies","volume":"1","author":"Buckley","year":"2005","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/toxsci\/68.1.9","article-title":"Ontogeny of the N-methyl-d-aspartate (NMDA) receptor system and susceptibility to neurotoxicity","volume":"68","author":"Haberny","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.autrev.2016.12.002_bb0060","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/art.22031","article-title":"Anti-N-methyl-d-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus","volume":"54","author":"Lapteva","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00415-011-6232-5","article-title":"Systemic lupus erythematosus, the brain, and anti-NR2 antibodies","volume":"259","author":"Lauvsnes","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0070","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","article-title":"NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo","volume":"27","author":"Liu","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2016.12.002_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-065X.2012.01137.x","article-title":"A model for lupus brain disease","volume":"248","author":"Diamond","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2016.12.002_bb0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00702-014-1193-3","volume":"121","author":"Levite","year":"2014","journal-title":"J Neural Transm"},{"key":"10.1016\/j.autrev.2016.12.002_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1134\/S0006297912020022","article-title":"NMDA receptors in immune competent cells","volume":"77","author":"Boldyrev","year":"2012","journal-title":"Biochemistry Biokhimiia"},{"key":"10.1016\/j.autrev.2016.12.002_bb0090","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/art.30616","article-title":"NR2-reactive antibody decreases cell viability through augmentation of Ca(2+) influx in systemic lupus erythematosus","volume":"63","author":"Gono","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/cne.903470112","article-title":"Differential expression of five N-methyl-d-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats","volume":"347","author":"Akazawa","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molmed.2012.01.008","article-title":"The DWEYS peptide in systemic lupus erythematosus","volume":"18","author":"Bosch","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2016.12.002_bb0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it's the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.rdc.2009.12.007","article-title":"Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus","volume":"36","author":"Aranow","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2016.12.002_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0065-2776(05)89007-8","article-title":"Immunity and acquired alterations in cognition and emotion: lessons from SLE","volume":"89","author":"Diamond","year":"2006","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0120","doi-asserted-by":"crossref","first-page":"10281","DOI":"10.3390\/ijms160510281","article-title":"Anti-NR2A\/B antibodies and other major molecular mechanisms in the pathogenesis of cognitive dysfunction in systemic lupus erythematosus","volume":"16","author":"Tay","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2016.12.002_bb0125","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1002\/art.38127","article-title":"Memory dysfunction in primary Sjogren's syndrome is associated with anti-NR2 antibodies","volume":"65","author":"Lauvsnes","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0130","first-page":"2093","article-title":"The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease?","volume":"31","author":"Senecal","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0135","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1073\/pnas.94.5.1955","article-title":"Peptide inhibition of glomerular deposition of an anti-DNA antibody","volume":"94","author":"Gaynor","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.12.002_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2796.2010.02318.x","article-title":"Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus","volume":"269","author":"Diamond","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2016.12.002_bb0145","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.12.002_bb0150","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.12.002_bb0155","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/rheumatology\/keq408","article-title":"Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus","volume":"50","author":"Gono","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.12.002_bb0160","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.12.002_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0170","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1523\/JNEUROSCI.0064-12.2012","article-title":"Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain","volume":"32","author":"Gleichman","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2016.12.002_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.07.015","article-title":"Identification of DNA-reactive B cells in patients with systemic lupus erythematosus","volume":"338","author":"Zhang","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2016.12.002_bb0180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ebiom.2015.05.027","article-title":"Selective impairment of spatial cognition caused by autoantibodies to the N-methyl-d-aspartate receptor","volume":"2","author":"Chang","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.autrev.2016.12.002_bb0185","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0190","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/art.39076","article-title":"Reply: to PMID 25156222","volume":"67","author":"Lauvsnes","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0195","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/art.22029","article-title":"Fulfilling Koch's postulates of autoimmunity: anti-NR2 antibodies in mice and men","volume":"54","author":"Pisetsky","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0200","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jclinepi.2005.03.004","article-title":"Searching one or two databases was insufficient for meta-analysis of observational studies","volume":"58","author":"Lemeshow","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0205","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.semarthrit.2011.11.002","article-title":"Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s","volume":"41","author":"Mak","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0210","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2016.12.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096407","article-title":"Blinded by PRISMA: are systematic reviewers focusing on PRISMA and ignoring other guidelines?","volume":"9","author":"Fleming","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.12.002_bb0220","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1468-1331.2004.00976.x","article-title":"Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors","volume":"12","author":"Omdal","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3102\/1076998609346961","article-title":"How many studies do you need?: a primer on statistical power for meta-analysis","volume":"35","author":"Valentine","year":"2009","journal-title":"J Educ Behav Stat"},{"key":"10.1016\/j.autrev.2016.12.002_bb0235","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/ard.2004.029280","article-title":"Autoantibodies to a NR2A peptide of the glutamate\/NMDA receptor in sera of patients with systemic lupus erythematosus","volume":"64","author":"Husebye","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.12.002_bb0240","first-page":"1553","article-title":"Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus","volume":"33","author":"Hanly","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0245","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/art.22030","article-title":"Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus","volume":"54","author":"Harrison","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0961203307078224","article-title":"Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives","volume":"16","author":"Steup-Beekman","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.12.002_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis","volume":"3","author":"Fragoso-Loyo","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.12.002_bb0260","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2010.04.016","article-title":"Antibodies against N-methyl-d-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes","volume":"295","author":"Kozora","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2016.12.002_bb0265","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3899\/jrheum.091366","article-title":"Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus","volume":"37","author":"Petri","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0270","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semarthrit.2011.02.005","article-title":"Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial","volume":"41","author":"Petri","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0275","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s12013-014-0010-9","article-title":"Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection","volume":"70","author":"Wang","year":"2014","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"10.1016\/j.autrev.2016.12.002_bb0280","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0961203314555538","article-title":"Anti-N-methyl-d-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus","volume":"24","author":"Massardo","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.12.002_bb0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2016.00005","article-title":"Antiglutamate receptor antibodies and cognitive impairment in primary antiphospholipid syndrome and systemic lupus erythematosus","volume":"7","author":"Gerosa","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0290","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.23218","article-title":"Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study","volume":"58","author":"Hanly","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.12.002_bb0295","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/ene.12946","article-title":"Migraine in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume but not with measures of glial activation or anti-NR2 or anti-P antibodies","volume":"23","author":"Tjensvoll","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/ar4518","article-title":"Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-d-aspartate receptor NR2 antibodies in diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"16","author":"Hirohata","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.12.002_bb0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2016.12.002_bb0310","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.12.002_bb0315","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2013-000007","article-title":"Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study","volume":"1","author":"Compagno","year":"2014","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2016.12.002_bb0320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrrheum.2011.200","article-title":"SLE in 2011: deciphering the role of NETs and networks in SLE","volume":"8","author":"Dorner","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0325","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/rheumatology\/keu384","article-title":"Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus","volume":"54","author":"Bortoluzzi","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.12.002_bb0330","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.12.002_bb0335","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/rheumatology\/kes261","article-title":"Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese","volume":"52","author":"Li","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.12.002_bb0340","first-page":"462841","article-title":"Pathogenic and epiphenomenal anti-DNA antibodies in SLE","volume":"2011","author":"Pavlovic","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2016.12.002_bb0345","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1373\/49.10.1752","article-title":"Blood test detecting autoantibodies to N-methyl-d-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke","volume":"49","author":"Dambinova","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2016.12.002_bb0350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2010.09.023","article-title":"NR2 antibodies: risk assessment of transient ischemic attack (TIA)\/stroke in patients with history of isolated and multiple cerebrovascular events","volume":"300","author":"Weissman","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2016.12.002_bb0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrrheum.2013.180","article-title":"Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases","volume":"10","author":"Meroni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.12.002_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144149","article-title":"25-Hydroxyvitamin D3 deficiency independently predicts cognitive impairment in patients with systemic lupus erythematosus","volume":"10","author":"Tay","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.12.002_bb9698","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew338","article-title":"Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot?","author":"Tay","year":"2016"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216302610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216302610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T11:17:15Z","timestamp":1568632635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216302610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1568997216302610"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.12.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A\/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sj\u00f6gren's syndrome: An updated meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}